Diabetes Treatment and Management Open access Peer reviewed

Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits

Chi Kin Wong, Daniel J. Drucker

Journal of Clinical Investigation | Nov 2, 2025 | 28 citations

Scollr summary

What this paper is about

Current understanding of the direct and indirect antiinflammatory effects and mechanisms of GLP-1 medicines in both preclinical and clinical studies are highlighted, covering emerging concepts, clinical relevance, and areas of uncertainty that require further investigation.

Full abstract

Read the full abstract

Therapies based on glucagon-like peptide-1 (GLP-1) reduce rates of cardiovascular and chronic kidney disease in people with type 2 diabetes and/or obesity, with ongoing clinical trials investigating their effects in people with metabolic liver disease, arthritis, and both substance use and neurodegenerative disorders. Acute and chronic activation of GLP-1 receptor signaling also reduces systemic and tissue inflammation in mice and humans, through weight loss-dependent and -independent mechanisms, actions that may contribute to the expanding spectrum of clinical benefits ascribed to GLP-1 medicines. In this Review, we highlight current understanding of the direct and indirect antiinflammatory effects and mechanisms of GLP-1 medicines in both preclinical and clinical studies, covering emerging concepts, clinical relevance, and areas of uncertainty that require further investigation.

Direct answer

What can I do from this paper page?

Use this page to scan "Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Diabetes Treatment and Management research, save the paper, or map adjacent work.

Authors

Researchers on this paper

Chi Kin Wong

first | Lunenfeld-Tanenbaum Research Institute | ORCID 0000-0003-4828-8413

Daniel J. Drucker

last | University of Toronto

Research areas

Follow related topics

Citation

BibTeX

@article{Wong2025Antiinflammatory,
  title = {Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits},
  author = {Chi Kin Wong and Daniel J. Drucker},
  journal = {Journal of Clinical Investigation},
  year = {2025},
  doi = {10.1172/jci194751},
  url = {https://doi.org/10.1172/jci194751}
}

FAQ

Using this paper in a discovery workflow

How do I find related work for this paper?

Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.

How can I keep up with new Diabetes Treatment and Management research papers?

Follow Diabetes Treatment and Management research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.

Can I cite this paper from this page?

This page includes a static BibTeX block for Antiinflammatory actions of glucagon-like peptide-1–based therapies beyond metabolic benefits. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.

Follow this research in Scollr

Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.

Get the app